Scholarlink

<p>IQGAP3, the most recently identified member of the IQGAP family of scaffolding proteins, is increasingly recognized as a key regulator of oncogenic signaling networks that govern tumor initiation and progression. IQGAP3 integrates multiple signaling pathways including RAS/MAPK, PI3K/AKT, Wnt/β-catenin, Hedgehog, ATM/Chk2–ATR/Chk1, and TGF-β, thereby modulating cellular processes such as proliferation, DNA repair, genomic stability, epithelial to mesenchymal transition, metastasis, stemness, and resistance to therapy.</p><p>This review offers a comprehensive overview of IQGAP3, beginning with its genomic organization and structural domains that underlie its distinct regulatory functions. We examine the physiological roles of IQGAP3 in cell cycle control, cytoskeletal organization, and early embryonic development, as well as its extensive network of interacting partners that link signaling pathways to specific cellular outcomes. We then highlight accumulating evidence implicating IQGAP3 dysregulation in oncogenesis, where it promotes tumor initiation, progression, and metastasis. Its contribution to therapy resistance further emphasizes its impact on clinical outcomes.</p><p>In conclusion, by integrating current insights into the IQGAP3 interactome and associated signaling networks, we position IQGAP3 as a central signaling hub at the intersection of normal cellular physiology and malignant transformation.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

IQGAP3, the overlooked oncogenic twin of IQGAP1: mapping its interactome and functional roles across cellular signaling and cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月30日

查看全文
  • Samudrajit Basu,
  • Manjusha Dixit

摘要

IQGAP3, the most recently identified member of the IQGAP family of scaffolding proteins, is increasingly recognized as a key regulator of oncogenic signaling networks that govern tumor initiation and progression. IQGAP3 integrates multiple signaling pathways including RAS/MAPK, PI3K/AKT, Wnt/β-catenin, Hedgehog, ATM/Chk2–ATR/Chk1, and TGF-β, thereby modulating cellular processes such as proliferation, DNA repair, genomic stability, epithelial to mesenchymal transition, metastasis, stemness, and resistance to therapy.

This review offers a comprehensive overview of IQGAP3, beginning with its genomic organization and structural domains that underlie its distinct regulatory functions. We examine the physiological roles of IQGAP3 in cell cycle control, cytoskeletal organization, and early embryonic development, as well as its extensive network of interacting partners that link signaling pathways to specific cellular outcomes. We then highlight accumulating evidence implicating IQGAP3 dysregulation in oncogenesis, where it promotes tumor initiation, progression, and metastasis. Its contribution to therapy resistance further emphasizes its impact on clinical outcomes.

In conclusion, by integrating current insights into the IQGAP3 interactome and associated signaling networks, we position IQGAP3 as a central signaling hub at the intersection of normal cellular physiology and malignant transformation.

Graphical abstract